• Japanese
  • Korean
  • Chinese
Cover Image

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam". It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

In 2013, Vietnam's population stood at 89.7 million, an increase from 85.1 million in 2008 due to the high birth rate and low mortality rate. The country's pharmaceutical market was estimated to have been worth $2.9 billion in 2013 and is expected to reach $8 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 15.4%. According to an EU Economic and Commercial Counsellor (EUECC) report in 2011, Vietnam's medical device market was estimated at approximately $220m in 2010 and is expected to grow at a CAGR of 10% to over $350m by 2015.

The positive trends in Vietnam's healthcare market can primarily be attributed to -

  • Increasing coverage of healthcare insurance
  • Government initiatives to improve healthcare facilities

Scope

This report provides information on the healthcare, regulatory, and reimbursement landscape in the Vietnam, including the following -

  • Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, GlaxoSmithKline, AstraZeneca, Novartis and DHG Pharmaceutical JSC
  • An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

The report will enhance your decision-making capability by allowing you to -

  • Develop business strategies through an understanding of the trends shaping and driving the healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of the Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Imports and Exports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Major Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Drug Price Trend
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. Licensing Process for Pharmaceutical Manufacturing
    • 4.2.4. Licensing Process for Pharmaceutical Exports and Imports
    • 4.2.5. Intellectual Property Rights
    • 4.2.6. Clinical Trial Regulations
    • 4.2.7. Pharmaceutical Advertising Regulations
    • 4.2.8. Pharmacy Regulations
    • 4.2.9. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of the Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Government Structural Balance
    • 5.3.9. General Government Net Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
    • 5.5.5. Healthcare Expenditure
  • 5.6. Trade Associations
    • 5.6.1. Vietnam Pharmaceutical Companies Association
    • 5.6.2. Vietnam General Association of Medicine and Pharmacy
    • 5.6.3. Vietnam Public Health Association
  • 5.7. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2013
  • Table 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2014-2020
  • Table 3: Pharmaceutical Market, Vietnam, Imports and Exports ($bn), 2008-2013
  • Table 4: Pharmaceutical Market, Vietnam, OTC, Major Segment Share (%), 2010
  • Table 5: Pharmaceutical Market, Vietnam, Major Disease Areas, Number of Cancer Cases, 2010
  • Table 6: Pharmaceutical Market, Vietnam, Major Disease Areas, Prevalence and Number of Mental Disorder Cases, 2005
  • Table 7: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013
  • Table 8: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014
  • Table 9: Pharmaceutical Market, GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 10: Pharmaceutical Market, Global, Late-Stage Pipeline, GlaxoSmithKline, 2014
  • Table 11: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue, 2013
  • Table 12: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014
  • Table 13: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 14: Pharmaceutical Market, Global, Planned Filings, Novartis, 2014-2018
  • Table 15: Pharmaceutical Market, DHG Pharmaceutical JSC, Global, Major Products, 2014
  • Table 16: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (%), 2008-2013
  • Table 17: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (million), 2008-2013
  • Table 18: Overview of Insurance Providers, Vietnam, Patient Share of Healthcare Expenditure (%), 2008-2013
  • Table 19: Healthcare Spending, Vietnam, Price Change (%), 2008-2012
  • Table 20: Regulatory Landscape, Vietnam, List of the Generic Drugs Required to Submit BE/BA at the Time of Approval, 2014
  • Table 21: Regulatory Landscape, Vietnam, Patent Filing Fees and Charges, 2014
  • Table 22: Regulatory Landscape, Vietnam, Trademark Filing Fees and Charges, 2014
  • Table 23: Regulatory Landscape, Vietnam, Labeling Guidelines, 2014
  • Table 24: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2013
  • Table 25: Economic Indicators, Vietnam, Forecast GDP per Capita ($), 2014-2020
  • Table 26: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2013
  • Table 27: Economic Indicators, Vietnam, Forecast GDP Annual Growth (%), 2014-2020
  • Table 28: Economic Indicators, Vietnam, GNI per Capita ($), 2008-2013
  • Table 29: Economic Indicators, Vietnam, Average Consumer Price Index, 2008-2013
  • Table 30: Economic Indicators, Vietnam, Average Consumer Price Index, Forecast, 2014-2020
  • Table 31: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), 2008-2013
  • Table 32: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), Forecast, 2014-2020
  • Table 33: Economic Indicators, Vietnam, Currency Exchange Rate (VND/$), 2008-2013
  • Table 34: Economic Indicators, Vietnam, Foreign Direct Investment ($bn), 2008-2013
  • Table 35: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2013
  • Table 36: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2013
  • Table 37: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2013
  • Table 38: Economic Indicators, Vietnam, General Government Structural Balance ($bn), 2008-2013
  • Table 39: Economic Indicators, Vietnam, General Government Net Debt (% of GDP), 2008-2013
  • Table 40: Economic Indicators, Vietnam, Major Industries, Turnover ($bn), 2011, 2012
  • Table 41: Demographics, Vietnam, Population (million), 2008-2013
  • Table 42: Demographics, Vietnam, Forecast Population (million), 2014-2020
  • Table 43: Demographics, Vietnam, Urban and Rural Population Share (%), 2008-2013
  • Table 44: Demographics, Vietnam, Forecast Urban and Rural Population Share (%), 2014-2020
  • Table 45: Demographics, Vietnam, Distribution by Age Group (%), 2008-2013
  • Table 46: Demographics, Vietnam, Forecast Distribution by Age Group (%), 2014-2020
  • Table 47: Demographics, Vietnam, Births (per 1,000 Population), 2008-2013
  • Table 48: Demographics, Vietnam, Mortality (per 1,000 Population), 2008-2013
  • Table 49: Demographics, Vietnam, Major Causes of Mortality ('000), 2008
  • Table 50: Demographics, Vietnam, Children <5 Mortality Rate (per 1,000 Live Births), 2008-2013
  • Table 51: Demographics, Vietnam, Immunization Rate (%), 2008-2013
  • Table 52: Demographics, Vietnam, Major Causes of Male Mortality ('000), 2008
  • Table 53: Demographics, Vietnam, Major Causes of Female Mortality ('000), 2008
  • Table 54: Demographics, Vietnam, Gender Ratio (M/F), 2008-2013
  • Table 55: Demographics, Vietnam, Life Expectancy at Birth (Years), 2008-2013
  • Table 56: Demographics, Vietnam, Forecast Life Expectancy at Birth (Years), 2014-2020
  • Table 57: Demographics, Vietnam, Gross Enrollment (%), 2008-2013
  • Table 58: Demographics, Vietnam, Unemployment (%), 2008-2013
  • Table 59: Demographics, Vietnam, Major Disease Prevalence (%), 2012
  • Table 60: Demographics, Vietnam, DALY (per 100,000 Population), 2004
  • Table 61: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2013
  • Table 62: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2013
  • Table 63: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 Population), 2008-2013
  • Table 64: Healthcare Infrastructure, Vietnam, Practicing Physicians (per 1,000 Population), 2008-2013
  • Table 65: Environmental Health, Vietnam, PM10 (µg/m3), 2008-2013
  • Table 66: Environmental Health, Vietnam, CO2 Emissions (million tons), 2008-2013
  • Table 67: Healthcare Personnel, Vietnam, Nurses (per 100,000 Population), 2008-2013
  • Table 68: Healthcare Personnel, Vietnam, Midwives (per 100,000 Population), 2008-2013
  • Table 69: Healthcare Personnel, Vietnam, Pharmacists (per 100,000 Population), 2008-2013
  • Table 70: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2013
  • Table 71: Healthcare Expenditure, Vietnam, Share of Major Components (%), 2007
  • Table 72: Healthcare Expenditure, Vietnam, Public-Private Share (%), 2008-2013
  • Table 73: Trade Fairs, Vietnam, Major Healthcare Trade Fairs, 2014

List of Figures

  • Figure 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2013
  • Figure 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2014-2020
  • Figure 3: Pharmaceutical Market, Vietnam, Imports and Exports ($bn), 2008-2013
  • Figure 4: Pharmaceutical Market, Vietnam, Distribution Chain, 2014
  • Figure 5: Pharmaceutical Market, Vietnam, OTC, Major Segment Share (%), 2010
  • Figure 6: Healthcare Market, Indonesia, Drivers and Barriers, 2014
  • Figure 7: Market Access, Vietnam, Healthcare System, 2014
  • Figure 8: Overview of Insurance Providers, Vietnam, Funding to Healthcare System, 2014
  • Figure 9: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (%), 2008-2013
  • Figure 10: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (million), 2008-2013
  • Figure 11: Overview of Insurance Providers, Vietnam, Patient Share of Healthcare Expenditure (%), 2008-2013
  • Figure 12: Healthcare Spending, Vietnam, Price Change (%), 2008-2012
  • Figure 13: Regulatory Landscape, Vietnam, New Drug Approval Process, 2014
  • Figure 14: Regulatory Landscape, Vietnam, Generic Drug Approval Process, 2014
  • Figure 15: Regulatory Landscape, Vietnam, Patent and Trademark Approval Process, 2014
  • Figure 16: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2013
  • Figure 17: Economic Indicators, Vietnam, Forecast GDP per Capita ($), 2014-2020
  • Figure 18: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2013
  • Figure 19: Economic Indicators, Vietnam, Forecast GDP Annual Growth (%), 2014-2020
  • Figure 20: Economic Indicators, Vietnam, GNI per Capita ($), 2008-2013
  • Figure 21: Economic Indicators, Vietnam, Average Consumer Price Index, 2008-2013
  • Figure 22: Economic Indicators, Vietnam, Average Consumer Price Index, Forecast, 2014-2020
  • Figure 23: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), 2008-2013
  • Figure 24: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), Forecast, 2014-2020
  • Figure 25: Economic Indicators, Vietnam, Currency Exchange Rate (VND/$), 2008-2013
  • Figure 26: Economic Indicators, Vietnam, Foreign Direct Investment ($bn), 2008-2013
  • Figure 27: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2013
  • Figure 28: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2013
  • Figure 29: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2013
  • Figure 30: Economic Indicators, Vietnam, General Government Structural Balance ($bn), 2008-2013
  • Figure 31: Economic Indicators, Vietnam, General Government Net Debt (%), 2008-2013
  • Figure 32: Economic Indicators, Vietnam, Major Industries, Turnover ($bn), 2011 and 2012
  • Figure 33: Demographics, Vietnam, Population (million), 2008-2013
  • Figure 34: Demographics, Vietnam, Forecast Population (million), 2014-2020
  • Figure 35: Demographics, Vietnam, Urban and Rural Population Share (%), 2008-2013
  • Figure 36: Demographics, Vietnam, Forecast Urban and Rural Population Share (%), 2014-2020
  • Figure 37: Demographics, Vietnam, Distribution by Age Group (%), 2008-2013
  • Figure 38: Demographics, Vietnam, Forecast Distribution by Age Group (%), 2014-2020
  • Figure 39: Demographics, Vietnam, Births (per 1,000 Population), 2008-2013
  • Figure 40: Demographics, Vietnam, Mortality (per 1,000 Population), 2008-2013
  • Figure 41: Demographics, Vietnam, Major Causes of Mortality ('000), 2008
  • Figure 42: Demographics, Vietnam, Children <5 Mortality Rate (per 1,000 Live Births), 2008-2013
  • Figure 43: Demographics, Vietnam, Immunization Rate (%), 2008-2013
  • Figure 44: Demographics, Vietnam, Major Causes of Male Mortality ('000), 2008
  • Figure 45: Demographics, Vietnam, Major Causes of Female Mortality ('000), 2008
  • Figure 46: Demographics, Vietnam, Gender Ratio (M/F), 2008-2013
  • Figure 47: Demographics, Vietnam, Life Expectancy at Birth (Years), 2008-2013
  • Figure 48: Demographics, Vietnam, Forecast Life Expectancy at Birth (Years), 2014-2020
  • Figure 49: Demographics, Vietnam, Gross Enrollment (%), 2008-2013
  • Figure 50: Demographics, Vietnam, Unemployment (%), 2008-2013
  • Figure 51: Demographics, Vietnam, Major Diseases Prevalence (%), 2012
  • Figure 52: Demographics, Vietnam, DALY (per 100,000 Population), 2004
  • Figure 53: Healthcare Infrastructure, Vietnam, Healthcare System, 2014
  • Figure 54: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2013
  • Figure 55: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2013
  • Figure 56: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 Population), 2008-2013
  • Figure 57: Healthcare Infrastructure, Vietnam, Practicing Physicians (per 100,000 Population), 2008-2013
  • Figure 58: Environmental Health, Vietnam, PM10 (µg/m3), 2008-2013
  • Figure 59: Environmental Health, Vietnam, CO2 Emissions (million tons), 2008-2013
  • Figure 60: Healthcare Personnel, Vietnam, Nurses (per 100,000 Population), 2008-2013
  • Figure 61: Healthcare Personnel, Vietnam, Midwives (per 100,000 Population), 2008-2013
  • Figure 62: Healthcare Personnel, Vietnam, Pharmacists (per 100,000 Population), 2008-2013
  • Figure 63: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2013
  • Figure 64: Healthcare Expenditure, Vietnam, Share of Major Components (%), 2007
  • Figure 65: Healthcare Expenditure, Vietnam, Public-Private Share (%), 2008-2013
  • Figure 66: Healthcare Market, Vietnam, Opportunities and Challenges, 2014
Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top